Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines.It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity.
The company’s product portfolio includes new-generation insulins, modern insulins, human insulins, oral antidiabetic agents, diabetes devices and others.Novo Nordisk also offers biopharmaceuticals for treating haemostasis, human growth hormone products, hormone replacement therapy and other serious chronic diseases.
With subsidiaries in Europe, North America, Asia, Latin America, Africa, Middle East and Australia, the company markets its products in several countries worldwide. Novo Nordisk is headquartered in Bagsvaerd, Denmark.
Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....
The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare expenses in emerging economies, and rising geriatric population increasing need of advanced medical technologies and devices. Also, innovations...
Italy Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2025 - Cranio Maxillofacial Fixation (CMF) Procedures
“Italy Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2025” is a comprehensive databook report, covering key procedures data on the Italy Cranio Maxillofacial...
The ostomy care market projected to grow at a CAGR of 4.4% over the forecast period of 2020-2025. The ostomy care market is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.4% during the forecast period. Globally, the population of individuals aged 60 years and above is expected to increase from 962...
Market Overview The market for medical electrodes is being driven by factors such as the increasing prevalence of cardiovascular and neurological diseases, increasing investment for technological advancements by biopharmaceutical companies and rising focus towards minimally invasive surgeries. The rising population...
This report forecasts to 2022 Canadian disposable medical supplies demand in nominal US dollars at the wholesale level. Total demand is segmented by product in terms of: surgical instruments and supplies; diagnostic and laboratory disposables; infusion and hypodermic devices; bandages and wound dressings; nonwoven medical...
Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals.The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering from blindness. It...
Summary Cyberonics, Inc. (Cyberonics) is a medical technology company that designs, develops and markets medical devices for the treatment of epilepsy and depression. The company offers vagus nerve stimulation therapy system used for treating refractory epilepsy and treatment-resistant depression. Its VNS therapy system consists...
United States Surgical Generators Market Outlook to 2023
GlobalData’s new report, "United States Surgical Generators Market Outlook to 2023", provides key market data on the United States Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and and average prices...
Oncology Market Access Europe – Payer and Industry Perspectives answers your questions: What are payers looking for when making decisions regarding oncology reimbursement? How are HTAs and other challenges affecting market access...
Health Care Provider
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.